Local News: Bonifay, FL 

 | 

Sign Up

 | 

Sign In

Advertisment

Merck News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Merck News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Merck News

News on Merck continually updated from thousands of sources around the net.

14 hrs ago | Free Republic

B vitamin outperforms another drug in keeping arteries clear

Adding a pharmaceutical form of the B vitamin niacin - but not the drug ezetimibe - to a cholesterol-lowering statin drug appears to reduce artery plaque buildup in patients with coronary artery disease, according to much-anticipated results announced at a press conference November 15.

Comment?

Related Topix: Medicine, Niacin (generic), Niaspan, Niacor, Medication, Zetia, Ezetimibe (generic), Biotech, Healthcare Industry, US Military, Walter Reed Army Medical Center, US Army

Yesterday | The Motley Fool

4-Star Stocks Poised to Pop: Merck

Based on the aggregated intelligence of 140,000-plus investors participating in Motley Fool CAPS , the Fool's free investing community, drug behemoth Merck has earned a respected four-star ranking .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets, Whitehouse Station, NJ, Schering Plough

Fri Nov 20, 2009

Medical News

EMEA's CHMP recommends approval of Merck's ELONVA

Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of ELONVAA as a treatment in controlled ovarian stimulation in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing, Health

Thu Nov 19, 2009

WGNO

Ligand Pharmaceuticals receives $2 million from research partnership with Merck

Ligand Pharmaceuticals Inc. said Thursday it received a $2 million milestone payment from Merck & Co.

Comment?

Related Topix: Biotech, Ligand Pharmaceuticals, Medicine, Healthcare Industry

Forbes

Answering The Vytorin Question

A trial showing that a form of niacin cleared arteries far better than Merck's Zetia cholesterol pill could have been disaster for the big drug maker.

Comment?

Related Topix: Zetia, Ezetimibe (generic), Medication, Biotech, Medicine, Healthcare Industry, Niacin (generic), Niaspan, Niacor, Cholesterol, Health, Public Relations

Wed Nov 18, 2009

ANA - Athens News Agency

15:04]( ... )- ' ' s Y - Y - BW-Higher Dose of Merck's COZAAR...

I'I I'IsIYI I I©I I- I I I IYI - BW-Higher Dose of Merck's COZAARA Signifi... src="http://mms.businesswire.com/bwapps/mediaserver/ViewMedia?mgid=57257&vid=2"> Nov.

Comment?

Related Topix: Medicine, Cozaar, Losartan Potassium (generic), Medication, Biotech, Healthcare Industry, Orlando Metro

HON

New Study Raises New Questions About Cholesterol Drug Zetia

A new study raises more questions about ezetimibe , a drug used by millions of Americans in tandem with statins to lower LDL, or "bad," cholesterol.

Comment?

Related Topix: Zetia, Ezetimibe (generic), Medication, Medicine, Cholesterol, Health, Niacin (generic), Niaspan, Niacor, Hospital Administration, Healthcare Industry, Biotech, Orlando Metro

Tue Nov 17, 2009

BNET

How Merck Lost $2.3B in the Bermuda Triangle

Merck must pay $2.3 billion in tax following a dispute with the IRS over cash the company parked in the Caribbean.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Tax, MarketWatch, Startups, Schering Plough

Small Times

Applied Materials, Merck and Braunschweig University Awarded Funding...

Applied Materials, Merck and Braunschweig University Awarded Funding by German Government for OLED Research Applied Materials, Inc., Merck KGaA and the Braunschweig University of Technology today announced that they have been awarded a grant by Germany's Federal Ministry of Education and Research to develop processes to lower the cost of ...

Comment?

Related Topix: Semiconductors, Biotech, Medicine, Electronics, Healthcare Industry, Applied Materials, Startups, World News, Germany

Mon Nov 16, 2009

USA Today

Even a small study on Zetia, Vytorin makes a big impact

It isn't often that a study involving a couple of hundred people shakes up medical science.

Comment?

Related Topix: Zetia, Ezetimibe (generic), Medication, Medicine, Niacin (generic), Niaspan, Niacor, Cholesterol, Health, Healthcare Law, Law, Biotech, Healthcare Industry

Sun Nov 15, 2009

KIDK TV

Study raises new questions about Merck pill Zetia

A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs that are still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.

Comment?

Related Topix: Zetia, Ezetimibe (generic), Medication, Biotech, Medicine, Healthcare Industry, Cholesterol, Health, Niacin (generic), Niaspan, Niacor, Cardiology, Whitehouse Station, NJ

Mayo Clinic

Gout affects women, too

Definition Gout is a complex form of arthritis characterized by sudden, severe attacks of pain, redness and tenderness in joints, often the joint at the base of the big toe.

Comment?

Related Topix: Medicine, Health, Gout, Arthritis, Biotech, Healthcare Industry, 9

Sat Nov 14, 2009

Drugs.com

Merck Strengthens Its Commitment to Advancing Cardiovascular Health Care

Nov 14, 2009 - Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a range of cardiovascular disorders.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing

Fri Nov 13, 2009

Drug Store News

Merck enrolls patients in late-stage trial for heart attack-preventing drug

WHITEHOUSE STATION, N.J. Merck & Co. has enrolled more than 26,000 patients in a late-stage clinical trial of a drug for preventing heart attacks, the pharmaceutical company announced Friday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Whitehouse Station, NJ

Thu Nov 12, 2009

BNET

Merck CEO Clark Eyes Retirement, and a $23M Golden Handshake

With the Schering-Plough merger done, Merck CEO Richard Clark is already mulling who will succeed him in the bosses' chair.

1 comment

Related Topix: Biotech, Medicine, Healthcare Industry, Schering Plough, Personal Finance, Retirement, 9

Wed Nov 11, 2009

Business World

New Merck begins world operations

Wednesday, November 04 14:23:26 The new Merck and Co, a product of the merger between Merck Sharp and Dohme and Schering-Plough and which employs 2,300 in Ireland, was launched globally today.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing, Ireland, World News,

Mon Nov 09, 2009

Memphis Business Journal

GTx loss widens in third quarter

GTx Inc. reported $3.6 million in third quarter revenue, a slight drop from the $3.8 million the company reported for the second quarter of 2009.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, GTx, Cancer, Health, Breast Cancer

Sun Nov 08, 2009

Myrtle Beach Online

The newest drugs may not always be the best

Last year pharmaceutical companies spent more than $4 billion urging patients like you to "ask your doctor" about their drugs.

Comment?

Related Topix: Drugs, Health, AARP, Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Cholesterol, Lipitor, Atorvastatin (generic), Medication

Sat Nov 07, 2009

Myrtle Beach Online

Pulte Homes, Merck, Garmin are big movers

The following stocks were among those that moved substantially or traded heavily Wednesday on the New York Stock Exchange: NYSE: Pulte Homes Inc., up 32 cents at $9.55 Motorola, Alcoa, Procter & Gamble are big movers Motorola, Alcoa, Procter & Gamble are big movers The following stocks were among those that moved substantially or traded heavily ...

Comment?

Related Topix: Construction, Pulte, Biotech, Cable & Satellite, Garmin, Telecom, Medicine, Healthcare Industry, Financial Markets, Wireless, Motorola

Fri Nov 06, 2009

BusinessWeek

U.S. executive pensions r...

Pensions for top U.S. executive rose by an average of 19 percent last year, and more than 200 officers saw their retirement savings surge by as much as 50 percent, even as their companies stock prices fell, the Wall Street Journal reported on Monday.

Comment?

Related Topix: Pension, Personal Finance, Biotech, Medicine, Healthcare Industry

Bonifay Jobs

Also on Topix